全文获取类型
收费全文 | 42595篇 |
免费 | 7919篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 782篇 |
儿科学 | 1325篇 |
妇产科学 | 1496篇 |
基础医学 | 3295篇 |
口腔科学 | 3189篇 |
临床医学 | 6676篇 |
内科学 | 9741篇 |
皮肤病学 | 756篇 |
神经病学 | 3450篇 |
特种医学 | 1728篇 |
外科学 | 6340篇 |
综合类 | 500篇 |
现状与发展 | 12篇 |
一般理论 | 35篇 |
预防医学 | 4947篇 |
眼科学 | 659篇 |
药学 | 2140篇 |
中国医学 | 17篇 |
肿瘤学 | 3586篇 |
出版年
2023年 | 1176篇 |
2022年 | 480篇 |
2021年 | 907篇 |
2020年 | 1394篇 |
2019年 | 802篇 |
2018年 | 1668篇 |
2017年 | 1554篇 |
2016年 | 1782篇 |
2015年 | 1867篇 |
2014年 | 2415篇 |
2013年 | 2965篇 |
2012年 | 1682篇 |
2011年 | 1676篇 |
2010年 | 1841篇 |
2009年 | 2397篇 |
2008年 | 1557篇 |
2007年 | 1457篇 |
2006年 | 1536篇 |
2005年 | 1335篇 |
2004年 | 1195篇 |
2003年 | 1097篇 |
2002年 | 1037篇 |
2001年 | 1108篇 |
2000年 | 1073篇 |
1999年 | 1043篇 |
1998年 | 747篇 |
1997年 | 697篇 |
1996年 | 748篇 |
1995年 | 623篇 |
1994年 | 508篇 |
1993年 | 458篇 |
1992年 | 695篇 |
1991年 | 694篇 |
1990年 | 656篇 |
1989年 | 656篇 |
1988年 | 595篇 |
1987年 | 609篇 |
1986年 | 537篇 |
1985年 | 500篇 |
1984年 | 430篇 |
1983年 | 379篇 |
1982年 | 307篇 |
1981年 | 253篇 |
1979年 | 317篇 |
1978年 | 309篇 |
1977年 | 240篇 |
1976年 | 232篇 |
1975年 | 220篇 |
1974年 | 233篇 |
1972年 | 216篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
4.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
5.
6.
7.
8.
9.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献